ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
- Written by Media Outreach
New York, New York - Newsfile Corp. - February 10, 2023 - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the "Class Period"), of the important March 20, 2023 lead plaintiff deadline.
SO WHAT: I...














